U.S. markets open in 3 hours 30 minutes
  • S&P Futures

    3,809.50
    -29.50 (-0.77%)
     
  • Dow Futures

    31,382.00
    -83.00 (-0.26%)
     
  • Nasdaq Futures

    12,434.50
    -229.25 (-1.81%)
     
  • Russell 2000 Futures

    2,167.40
    -22.30 (-1.02%)
     
  • Crude Oil

    66.12
    +0.03 (+0.05%)
     
  • Gold

    1,689.10
    -9.40 (-0.55%)
     
  • Silver

    25.33
    +0.04 (+0.15%)
     
  • EUR/USD

    1.1882
    -0.0043 (-0.36%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    27.57
    -1.00 (-3.50%)
     
  • GBP/USD

    1.3845
    +0.0017 (+0.12%)
     
  • USD/JPY

    108.4970
    +0.1150 (+0.11%)
     
  • BTC-USD

    50,141.49
    -799.44 (-1.57%)
     
  • CMC Crypto 200

    1,014.66
    +71.49 (+7.58%)
     
  • FTSE 100

    6,619.73
    -10.79 (-0.16%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

$4.5 Billion Negative Pressure Wound Therapy Devices (Conventional, Single-Use, Accessories) Markets - Global Industry Analysis and Growth Forecast to 2030 - ResearchAndMarkets.com

·5 min read

The "Negative Pressure Wound Therapy Devices Market Research Report: By Product (Conventional, Single-Use, Accessories), Wound Type (Chronic, Acute), End User (Hospitals, Home-Care Settings) - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The global negative pressure wound therapy (NPWT) devices market was valued at $2,178.4 million in 2019 and is expected to reach to $4,541.5 million by 2030, at a 7.3% CAGR between 2020 and 2030

The negative pressure wound therapy devices market is witnessing a slowdown during the COVID-19 scenario, as the badly hit supply chains have resulted in the low manufacturing and trade of NPWT products. Moreover, with the focus of the healthcare industry on treating COVID patients, burns departments of the majority of hospitals are non-operational.

North America has been the highest revenue contributor to the negative pressure wound therapy devices market till now. The prevalence of diabetes and, in turn, of foot ulcers, is rising in the U.S. As per the CDC, 34.2 million people in the U.S. had diabetes in 2018, which was the seventh-largest cause of mortality in the nation that year. Additionally, the country also has a large geriatric population, in which wounds heal slowly, thus necessitating the usage of NPWT devices.

The negative pressure wound therapy devices market is predicted to witness the most rapid advance in the APAC region in the years to come. The demand for NPWT devices is increasing in here on account of the rising incidence of diabetes, regular product launches, and growing healthcare expenditure by regional nations.

Further, with the strong focus of the healthcare fraternity on making patients comfortable and providing quick wound treatment, NPWT device manufacturers in the region are bringing about technological advancements in their products.

Key Topics Covered:

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Conventional

4.1.1.2 Single-use

4.1.1.3 Accessories

4.1.2 By Wound Type

4.1.2.1 Chronic

4.1.2.1.1 Venous ulcers

4.1.2.1.2 Diabetic foot ulcers

4.1.2.1.3 Pressure ulcers

4.1.2.2 Acute

4.1.2.2.1 Burns

4.1.2.2.2 Surgical

4.1.2.2.3 Others

4.1.3 By End User

4.1.3.1 Hospitals

4.1.3.1.1 In-patient

4.1.3.1.2 Out-patient

4.1.3.2 Home-care settings

4.1.3.3 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Shift in preference toward advanced wound therapies

4.2.2 Drivers

4.2.2.1 Increasing cases of burns

4.2.2.2 Rising prevalence of diabetes

4.2.2.3 Growing geriatric population

4.2.2.4 High rate of C-section surgeries leading to increasing post-operative use of NPWT devices

4.2.2.5 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High treatment costs

4.2.3.2 Complications associated with NPWT devices

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Adoption of NPWT devices in low- and middle-income and war affected nations

4.2.4.2 Improving economic status of countries

4.1 Impact of COVID-19

4.1.1 Supply Side Analysis

4.1.1.1 Current scenario of major manufactures and exporters of NPWT devices

4.1.1.2 Situation of lockdown and workforce availability

4.1.1.3 Production scenario

4.1.1.4 Situation of major countries supplying raw materials

4.1.2 Demand Side Analysis

4.2 Porter's Five Forces Analysis

4.3 Regulatory Scenario

4.4 Epidemiology of Chronic Wounds in 7MM

4.5 Comparison of NPWT and Conventional Wound Therapies

4.6 Reimbursement Policies

4.6.1 Healthcare Common Procedure Coding System (HCPCS) Codes

4.6.1.1 Current procedural technology (CPT) codes

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.2 By Wound Type

5.2.1 NPWT Devices Market for Chronic Wounds, by Type

5.2.2 NPWT Devices Market for Acute Wounds, by Type

5.3 By End User

5.3.1 NPWT Devices Market in Hospitals, by Type

5.4 By Region

Chapter 6. North America Market Size and Forecast

Chapter 7. Europe Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Competitive Landscape

11.1 Key Players Benchmarking Based on Product Type

11.2 Strategic Developments of the Key Players

Chapter 12. Company Profiles

12.1 Business Overview

12.2 Product and Service Offerings

  • Devon International Group

  • DeRoyal Industries Inc.

  • ConvaTec Group plc

  • Smith & Nephew plc

  • Molnlycke Health Care AB

  • Acelity L.P. Inc.

  • ATMOS MedizinTechnik GmbH & Co. KG

  • Talley Group Limited

  • Cardinal Health Inc.

  • Medela AG

  • Lohmann & Rauscher GmbH & Co. KG

  • Carilex Medical GmbH

  • TRIAGE MEDITECH PVT. LTD.

  • Shandong Weigao Xinsheng Medical Devices Co. Ltd.

  • B. Braun Melsungen AG

  • Genadyne Biotechnologies Inc.

  • BSN medical GmbH

  • Cork Medical LLC

For more information about this report visit https://www.researchandmarkets.com/r/2drw0n

View source version on businesswire.com: https://www.businesswire.com/news/home/20201125005828/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900